• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同期超选择性动脉内化疗和放疗治疗晚期颞骨鳞状细胞癌

Concurrent superselective intra-arterial chemotherapy and radiotherapy for late-stage squamous cell carcinoma of the temporal bone.

作者信息

Sugimoto Hisashi, Ito Makoto, Yoshida Shinya, Hatano Miyako, Yoshizaki Tomokazu

机构信息

Department of Otolaryngology-Head and Neck Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

出版信息

Ann Otol Rhinol Laryngol. 2011 Jun;120(6):372-6. doi: 10.1177/000348941112000604.

DOI:10.1177/000348941112000604
PMID:21774443
Abstract

OBJECTIVES

This study evaluated the efficacy of concurrent superselective intra-arterial chemotherapy and radiotherapy without surgery for late-stage squamous cell carcinoma of the temporal bone, which typically has a poor prognosis.

METHODS

The subjects were 5 patients treated at our hospital between 2007 and 2010 for primary cancer of the temporal bone. One patient had a stage T3 tumor, and 4 patients had T4 tumors, according to the Pittsburgh staging system. All patients received irradiation with a conventional once-daily fraction of 2 Gy, and the total dose ranged from 60 to 66 Gy. Intra-arterial cisplatin via transfemoral catheterization and intravenous sodium thiosulfate were administered. The contribution of each vessel in supplying blood to the primary tumor was determined by real-time computed tomographic angiography.

RESULTS

Three patients obtained a complete response. The same 3 patients remain alive without local recurrence (mean survival, 28 months), 1 patient died of distant metastasis without local recurrence after 19 months, and 1 patient remains alive with local recurrence.

CONCLUSIONS

Although the small number of patients prevents comparisons with other treatments, the present study obtained good results. This may become an effective treatment for patients with late-stage squamous cell carcinoma of the temporal bone.

摘要

目的

本研究评估了同期超选择性动脉内化疗与放疗而非手术治疗晚期颞骨鳞状细胞癌的疗效,这类癌症通常预后较差。

方法

研究对象为2007年至2010年间在我院接受颞骨原发性癌症治疗的5例患者。根据匹兹堡分期系统,1例患者为T3期肿瘤,4例患者为T4期肿瘤。所有患者均接受常规每日一次、每次2 Gy的照射,总剂量为60至66 Gy。通过经股动脉插管给予动脉内顺铂和静脉注射硫代硫酸钠。通过实时计算机断层血管造影确定各血管对原发性肿瘤的供血贡献。

结果

3例患者获得完全缓解。这3例患者仍存活且无局部复发(平均生存期28个月),1例患者在19个月后死于远处转移而无局部复发,1例患者存活但有局部复发。

结论

尽管患者数量较少,无法与其他治疗方法进行比较,但本研究取得了良好的结果。这可能成为晚期颞骨鳞状细胞癌患者的一种有效治疗方法。

相似文献

1
Concurrent superselective intra-arterial chemotherapy and radiotherapy for late-stage squamous cell carcinoma of the temporal bone.同期超选择性动脉内化疗和放疗治疗晚期颞骨鳞状细胞癌
Ann Otol Rhinol Laryngol. 2011 Jun;120(6):372-6. doi: 10.1177/000348941112000604.
2
Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.采用超选择性颞浅动脉内动脉灌注每日同步放化疗保肢治疗 T3 和 T4 头颈部癌症。
Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1428-35. doi: 10.1016/j.ijrobp.2010.01.011. Epub 2010 Jun 3.
3
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].[IV期非小细胞肺癌患者放疗后的生存状况——附287例报告]
Ai Zheng. 2006 Nov;25(11):1419-22.
4
Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.顺铂动脉内灌注化疗联合放疗治疗Ⅲ期宫颈癌鳞状细胞癌
Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):369-77. doi: 10.1016/j.ijrobp.2009.02.081.
5
Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: a prospective study.对于可切除的晚期头颈部鳞状细胞癌,采用强度低于RADPLAT的动脉内化疗联合同期放疗:一项前瞻性研究。
Ann Otol Rhinol Laryngol. 2007 Oct;116(10):754-61. doi: 10.1177/000348940711601007.
6
Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.包括术后放疗以及每周使用多西他赛进行同步化疗在内的多模式治疗,对于口腔癌和口咽癌患者而言是可行且有效的。
Strahlenther Onkol. 2005 Jan;181(1):26-34. doi: 10.1007/s00066-005-1272-3.
7
Intra-arterial cisplatin with concomitant radiation for advanced hypopharyngeal cancer.动脉内顺铂联合放疗治疗晚期下咽癌。
Laryngoscope. 2013 Apr;123(4):916-22. doi: 10.1002/lary.23870. Epub 2012 Dec 21.
8
Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.头颈部鳞状细胞癌的调强放射治疗——爱荷华大学的经验
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21. doi: 10.1016/j.ijrobp.2005.02.025.
9
Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.对上颌窦持续性或复发性癌症患者在超选择性动脉内输注顺铂并同步放疗后的挽救手术。
Br J Oral Maxillofac Surg. 2014 Apr;52(4):323-8. doi: 10.1016/j.bjoms.2014.01.018. Epub 2014 Feb 26.
10
[The outcome of treatments for carcinoma of the external auditory canal].[外耳道癌的治疗结果]
Rev Laryngol Otol Rhinol (Bord). 2005;126(3):165-70.

引用本文的文献

1
A retrospective analysis of radiotherapy in the treatment of external auditory canal carcinoma.外耳道癌放射治疗的回顾性分析
Mol Clin Oncol. 2021 Mar;14(3):45. doi: 10.3892/mco.2021.2207. Epub 2021 Jan 13.
2
Organ preservation following radiation therapy and concurrent intra-arterial low dose cisplatin infusion for advanced T2 and T3 laryngeal cancer: Long-term clinical results from a pilot study.放疗联合同期动脉内低剂量顺铂输注治疗晚期T2和T3喉癌后的器官保留:一项前瞻性研究的长期临床结果
Laryngoscope Investig Otolaryngol. 2020 Jan 8;5(1):55-65. doi: 10.1002/lio2.346. eCollection 2020 Feb.
3
Survival impact of local extension sites in surgically treated patients with temporal bone squamous cell carcinoma.
颞骨鳞状细胞癌手术治疗患者局部扩展部位的生存影响
Int J Clin Oncol. 2017 Jun;22(3):431-437. doi: 10.1007/s10147-016-1076-8. Epub 2017 Jan 2.